<HTML><HEAD><META http-equiv="Content-type" content="text/html;charset=UTF-8"></HEAD><BODY><DIV><P><BR>               <BR>               <BR>               DESCRIPTION<BR>               Propranolol hydrochloride, USP is a synthetic beta-adrenergic receptor-blocking agent chemically described as 2-Propanol, 1-[(1-methylethyl)amino]-3-(1-naphthalenyloxy)-, hydrochloride,(Its molecular and structural formulae are:<BR><BR>                  <BR>                  <BR><BR>                  <BR><BR>                  <BR><BR>                  <BR>C16H21NO2<BR>Propranolol hydrochloride is a stable, white, crystalline solid which is readily soluble in water and ethanol. Its molecular weight is 295.80.<BR>Propranolol hydrochloride extended-release is formulated to provide a sustained release of propranolol hydrochloride. Propranolol hydrochloride extended-release is available as 60 mg, 80 mg, 120 mg, and 160 mg capsules for oral administration.<BR>The inactive ingredients contained in propranolol hydrochloride extended-release capsules, are: ethylcellulose, gelatin, hydroxypropyl cellulose, povidone, sugar spheres, talc, titanium dioxide. In addition, the 60 mg and 80 mg capsule shells contain yellow iron oxide. The 120 mg capsule shells contain black iron oxide and yellow iron oxide. The 160 mg capsule shells contain black iron oxide. The ink ingredients are common for all strengths: Opacode S-1-8114 or Opacode S-1-8115 black contains: D&C Yellow #10 Aluminum Lake, FD&C blue #1 Aluminum lake, FD&C Blue #2 Aluminum Lake, FD&C Red #40 Aluminum Lake, pharmaceutical glaze, propylene glycol, and synthetic black iron oxide.<BR>This drug product complies with USP Drug Dissolution Test 1.<BR><BR>                  <BR><BR>               <BR>               <BR>               <BR>                  <BR>                     MM1<BR>                     <BR>                        <BR>                     <BR>                  <BR>               <BR>            <BR>         </P></DIV></HTML>